Biocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Aditi Kare Panandikar receives the Ohio State University Award
She get the award for her outstanding contribution to the pharmaceutical industry
Aditi Kare Panandikar, Managing Director,…
CII launches online certification courses on IPR
Lecturers to be experienced legal luminaries, academicians and stalwarts with a say in shaping India’s IPR policy
Wockhardt recalls 12 drugs in US made at 2 India units
Wockhardt said this was a measure of preparedness and abundant precaution and there is no evidence of risk to patient safety from…
Carbopol Workshop – Oral Formulations
Lubrizol LifeSciences will organise Carbopol Workshop – Oral Formulations
3 Indian cos receive US FDA nod for 1st generic Abilify to treat mental illnesses
Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals have received FDA approval to market…
Syngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene
Cadila Pharma celebrates World Day for Safety and Health at Work
Activities conducted at Bhat, Dholka, Ankleshwar, Kadi and Hirapur locations to commemorate International Labour Organisation
Mylan rejects Teva’s $40 bn offer as ‘gross undervaluation’
Says, "bringing Teva's 'dysfunctional' culture to the region (India) could disrupt the core of its business, result in the flight…